Pharmacogenetics

Single nucleotide polymorphisms may predict opioid use disorder

2 November 2021

Underrepresented patient views on personalised medicine

Genomics week in brief: Week ending 12th June

4 February 2021

Pharmacogenetic testing could save millions

27 November 2020

Barriers and facilitators to implementing pharmacogenomic screening

The potential role of PGx in managing experimental therapies for COVID-19

Pharmacogenomics: Drugs, DNA and dosage

27 February 2020

New pharmacogenomics solution launched in the US

21 February 2020

FDA releases list of evidence-based pharmacogenetic variants

30 January 2020

FoG 2020 Presentation Andrea Jorgensen, University of Liverpool